Mitsubishi Tanabe Pharma Corporation, et al. v. Sandoz Inc., et al.
Aug 23, 2016OUTCOME: pending
Lead counsel for InvaGen in multi-defendant first-to-file ANDA case regarding canagliflozin (INVOKANA®) and canagliflozin + metformin (INVOKAMET®).
Tedd W. Van Buskirk's Legal Cases (26)
Cranford, NJ
Intellectual property Lawyer at Cranford, NJ
Practice Areas: Intellectual Property, Life Sciences & Biotechnology ... +4 more
Prometheus Laboratories Inc. v. Amneal Pharmaceuticals, LLC et al.
Jul 23, 2014OUTCOME: pending
Represent Amneal defendants in Hatch-Waxman litigation relating to LOTRONEX (alosetron HCl).
Life Brands v. Monsterops
Oct 26, 2012OUTCOME: Favorable settlement
Defended Monsterops, T Nation, and Biotest in trademark infringement litigation over the mark BRAIN CANDY. Settled with defendants acquiring all rights to BRAIN CANDY marks.
Endo v. Noven
Jun 28, 2012OUTCOME: Settled April 2014
Lead counsel for Noven Pharmaceuticals in Hatch-Waxman litigation arising out of Noven's ANDA for topical lidocaine patch 5% marketed by Endo as LIDODERM®.
Helsinn Healthcare S.A., et al. v. Dr. Reddy's Laboratories, Ltd. et al.
May 11, 2012OUTCOME: pending
Counsel for DRL in Hatch-Waxman litigation arising out of DRL's 505(b)(2) NDA for palonosetron HCL intravenous solution.
B&E Dimensional Stoneworks v. Wicki et al.
Jul 12, 2011OUTCOME: Plaintiff dismissed case in April 2013
Lead counsel for defendant Simonfay Landscape Services in trademark infringement litigation regarding Plaintiff's KEARNEY STONE mark.
Shire v. Taro
Jan 01, 2010OUTCOME: Favorable settlement
Lead counsel. Obtained covenant not to sue and license from Shire LLC on behalf of Taro through Hatch-Waxman litigation involving the anticonvulsant drug CARBATROL® (carbamazepine).
Medicis v. Taro
Jan 01, 2010OUTCOME: Favorable settlement
Lead counsel. Achieved favorable settlement of dismissal with prejudice and early generic entry for Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. in Hatch-Waxman litigation ... over VANOS® (fluocinonide) cream 0.1% brought by Medicis Pharmaceutical Corp.
CIMA Labs Inc. v. Novel Laboratories Inc.
Nov 25, 2008OUTCOME: Settled December 2014
Represented Novel in Hatch-Waxman litigation relating to FAZACLO (clozapine)
Takeda v. Teva
Jan 01, 2008OUTCOME: Trial verdict, affirmed on appeal
Secured trial verdict and permanent injunction in favor of Takeda Pharmaceutical Company Ltd. in Hatch-Waxman litigation to protect PREVACID® (lansoprazole) from a challenge by Teva, the world’s larges ... t generic pharmaceutical company. PREVACID, a proton pump inhibitor, was one of the top-10 selling drugs in the world with annual sales in excess of $4 billion.
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
